Developer docs
API playgroundTry for free, no card

Search company profiles

MetGen

Full company profile

uuid0003v3a

Namestring
MetGen
Legal namestring
MetGen Oy
Websiteurl
metgen.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

MetGen Oy is a Finnish industrial biotechnology company founded in 2008 and headquartered in Kaarina, Finland with a second site in Geleen, Netherlands. The company designs and produces tailored industrial enzymes and enzymatic lignin-refining processes, built on two proprietary platforms: the ENZINE® protein-evolution and fermentation platform (capable of moving from concept to industrial enzyme production in under 12 months) and the METNIN™ lignin-refining technology (an enzymatic process operating at pH 11 and elevated temperatures to depolymerize and fractionate any lignin source into tailored molecular weight cuts). These platforms power a portfolio of MetZyme® enzyme products (LIGNO™, PLATA™, BRILA™, SUNO™, PURECO™) for pulp & paper and biorefinery applications, plus a family of formulated METNIN™ end-products (SHIELD, RESIN, NANOpolyol, Bioesters, and MICRO/ULTRA/NANO Fractions) for packaging, foams, resins, adhesives, and bioplastics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKaarina, Finland
HQ citystring
Kaarina
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
industrial enzymes, lignin refining, biorefinery solutions, pulp and paper enzymes, bio-based materials
Industry3 codes
PRIMARYIMAMALAB
Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids)
SECONDARYIMAMALAE
Lignin-based Materials & Carbon Products (binders, resins, carbon fiber/activated carbon)
SECONDARYEUAAAHAJ
Biofuel Co-products & Byproduct Processing (DDGS, Glycerin, CO2, Lignin)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biofuels Production (Ethanol, Biodiesel, Renewable Diesel, SAF)
NAICS code2 codes
  • Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing325194
  • Other Basic Organic Chemical Manufacturing32519
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Miscellaneous Chemical Products2890
Product category
Industrial Enzymes & Bio-Based Specialty Chemicals
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Technology Licensing (METNIN™ and Enzyme Production Systems)
TypeLicensing Royalties
Description

License fees plus potential royalties on METNIN™ lignin refining technology and enzyme production systems (e.g., SUNO™), with territory-specific and biorefinery-count licensing. Includes EPCM for licensees to build their own production sites.

metgen.com
2Direct Enzyme Product Sales (MetZyme®)
TypeTransaction Fee
Description

Direct supply of tailored MetZyme® industrial enzyme products (BRILA™, LIGNO™, PLATA™, etc.) to P&P mills, biorefineries and packaging customers; MetGen has shipped material to Asia, North and South America, with capacity up to 5,000L deliveries.

metgen.com
3Joint Development & Co-Creation Revenue
TypeProfessional Services
Description

Phased joint development engagements (3-month screening + 6–12 month genetic engineering) for co-creation of new enzymes and bioprocesses with industrial partners; fees dependent on manufacturing site selection and ownership/user rights.

metgen.com
4Public-Funded Project Grants (Horizon 2020 / BBI JU)
TypeProfessional Services
Description

Participation in 11 EU Horizon 2020 / BBI JU projects across consortia (e.g., SWEETWOODS with 21 M€ EU funding out of 43 M€ total project budget), contributing to over 110 M€ in total value-chain funding that supports technology development.

metgen.com
5METNIN™ Lignin Product Sales & Samples
TypeTransaction Fee
Description

Sales of formulated ready-to-use METNIN™ end-products (SHIELD, RESIN, NANOpolyol, Bioesters) and tailored lignin fractions (MICRO, ULTRA, NANO) with sample webshop for industrial customers.

metgen.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Custom licensing of METNIN™ technology and enzyme production systems — quote-based, includes license fees and potential royalties
ModelOtherBilling cadenceMulti-year contract
Notes

METNIN™ full process license covers specific substrate, end-products, and geographic areas; may include royalties and enzyme supply agreement. Enzyme production system license includes production strains, process technologies, and optional EPCM services for building licensee-owned sites.

metgen.com
2Joint Development phased program — project-based fees over screening and engineering phases
ModelOtherBilling cadenceMulti-year contract
Notes

Screening phase: up to 3 months. Genetic engineering phase: 6–12 months; cost affected by manufacturing site, ownership, and user rights of developed solutions.

metgen.com
3Custom enzyme product pricing (MetZyme®) — quote-based per customer substrate and volume
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Pricing is bespoke based on tailored enzyme cocktails; MetGen has demonstrated ability to supply up to 5,000L volumes and target enzyme concentrate volumes of 500m³/annum.

metgen.com
4METNIN™ end-product sales with sample webshop
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Sample-level entry via webshop; bulk pricing quote-based. SHIELD, RESIN, NANOpolyol, Bioesters and MICRO/ULTRA/NANO lignin fractions priced per customer specifications (pH, molecular weight, dry, solubility, viscosity, particle size, purity).

metgen.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1ENZINE®
Description

Technology platform combining protein evolution technology and fermentation, enabling recombinant expression of tailored enzymes that meet customer needs. Allows development of novel enzymes from idea to industrial production in less than 12 months.

metgen.com
+12 more records
Core offering1 text field

MetGen designs, develops, and manufactures tailored industrial enzymes and lignin-based biochemicals through two proprietary technology platforms: the ENZINE® protein-evolution and fermentation platform and the METNIN™ enzymatic lignin refining technology. The company sells MetZyme® enzyme products (LIGNO™, PLATA™, BRILA™, SUNO™, PURECO™) to pulp & paper mills and biorefinery operators, and formulated METNIN™ end-products (SHIELD, RESIN, NANOpolyol, Bioesters, and MICRO/ULTRA/NANO Fractions) to packaging, foam, resin, and bioplastics manufacturers. Commercialization routes include direct product sales, technology licensing, and joint development engagements with industrial customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MetGen delivers an integrated industrial biotechnology offering built on two proprietary technology platforms — the ENZINE® enzyme creation platform and the METNIN™ lignin refining process — which together power a portfolio of tailored MetZyme® enzyme products (LIGNO™, PLATA™, BRILA™, SUNO™, PURECO™) and a family of formulated METNIN™ lignin-based end-products (SHIELD, RESIN, NANOpolyol, Bioesters, and MICRO/ULTRA/NANO Fractions). These platforms and products are commercialized to industrial customers via four service lines: Biorefinery Solutions, Fibre Solutions, Licensing, and Joint Development. The product family is architected so ENZINE® generates the enzymes, MetZyme® products apply them to pulp-and-paper and biorefinery processes, and METNIN™ refines the lignin side-stream into value-added biochemicals — together creating a complete bio-based value chain from biomass to ready-to-use end products.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierMinorTypeOthersAnnounced on2025-11-26
Description

MetGen listed as one of key industry players profiled in ResearchAndMarkets.com's Biofuel Enzymes Market Forecast 2025-2030 report. Global biofuel enzymes market projected to grow from USD 1.580 billion (2025) to USD 2.268 billion (2030) at 7.50% CAGR. Other profiled players include DuPont, Iogen Corporation, Novozymes, Codexis Inc.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-11-11
Description

Commercial integration announced November 11, 2024 combining NewEnergyBlue's biomass conversion technologies with MetGen's enzyme and lignin fractionization capabilities. NewEnergyBlue's first U.S. biomass refinery in Mason City, Iowa expected to begin operations in 2027, producing 21M gallons biofuel and 150,000 tons clean lignin. Plans call for four additional American refineries fully incorporating Inbicon and MetGen technologies over five years. MetGen planning commercial lignin-to-chemicals project next to Kaarina laboratories for early 2026.

3EnXylaScope Consortium (5 SMEs, 4 research institutes, 2 large industrial partners, 2 universities)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

EU-funded project consortium developing enzymes for unleashing xylan potential for consumer products in cosmetics, nutraceuticals, and personal care sectors. Encompasses culture collections, enzyme discovery, production systems, xylan production and modification, consumer product development and evaluation, scaled-up enzyme production, and LCA/sustainability assessment.

metgen.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

EU-funded BIONEER project aims to scale-up lignocellulosic biomass-derived platform chemicals (BIONEER Building Blocks) to replace bisphenol A derivatives, alkyl acrylates, vinyl pyrrolidine, vinyl acetate, and siloxanes in personal care and coatings markets. Builds on EnXylaScope and PERFECOAT RIA projects.

5REDYSIGN Consortium
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

EU-funded REDYSIGN project developing bio-based, intelligent, and recyclable packaging for fresh meat distribution. Leverages lignocellulosic fibres, lignin, and sugars with integrated sensors for spoilage detection and cold chain monitoring; aims to advance recycling efficiency via identification markers and oxidation treatments.

metgen.com
6ROBUSTOO Consortium (Gecco, bisy, InnoSyn, BSC, CIB, UAB, IRNAS, FCBA, ITB)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

EU-funded ROBUSTOO project for large-scale production of oxidative enzymes (unspecific peroxygenases, laccases, HMFOs) for bio-based chemicals and materials. Applications include bio-based resins for wood panels/3D printing, regio-/stereo-selective oxygenations for fine chemicals, and FDCA production from HMF.

metgen.com
7Repsol
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-10-27
Description

MetGen won PITCCH 3rd Corporate Challenge round where Repsol sought SMEs with lignin conversion technology. Repsol will work on Proof of Concept together with MetGen on lignin valorization (METNIN products for packaging, resin and foam). Identified via PITCCH open innovation network which promotes collaborations between Big Corporations and SMEs/startups.

metgen.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-28
Description

Memorandum of Understanding announced September 28, 2022 to bring METNIN™ refineries to market and jointly sell and execute EPC projects. Global engineering company shares mission of maximizing biomass value and replacing petrochemicals. Collaboration leverages Technip Energies' engineering, procurement and construction capabilities alongside MetGen's METNIN™ lignin refining technology.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-21
Description

Joint Development Agreement announced September 21, 2022 with Oxford-based cultivated meat company. Agreement is powered by MetGen's ENZINE® Technology platform and aims to address food system climate impact through innovative science and technology.

Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2022-09-20
Description

License agreement (announced September 20, 2022) for Futurity to build and operate lignin-centric biorefineries using METNIN® Technologies in New Zealand. Futurity operates plantation forestry-based biorefinery in Tairāwhiti-Gisborne, producing Nano-fibrillated cellulose, PHBV and advanced lignins. License covers production of full range of high value lignin-based products including resins and adhesives, foams, composites, bio-based chemicals and polymers.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Industry consortium leader of SWEETWOODS EU Flagship project (43 M€ total budget, 21 M€ EU grant under Horizon 2020 BBI). Brings together MetGen Oy, Global Bioenergies, Tecnaro GmbH, Armacell via Ultima GmbH, Recticel N.V., 2B Srl, Vertech Group and Spinverse Oy. MetGen contributes four novel biorefinery solutions: Tailored hydrolysis (SUNO™), Enzymatic lignin depolymerization (METNIN™), Lignocellulosic glucose isomerization (PURECO™), Glucose conversion to glucosone.

12WoodZymes Consortium (Navigator Company, Fibre Excellence, FINSA, SOPREMA France, CIB, IRNAS, IATA-CSIC, RAIZ, CTP, FCBA)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Consortium for WOODZYMES project (H2020/BBI JU 2018-2021) developing wood transforming enzymes (extremozymes) for pulp & paper, fibreboard manufacture, and insulation materials sectors. Brings together world-leading companies and research institutes from Portugal, France, Finland and Spain.

metgen.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Consortium partner in ReTAPP project (Coordinator: MetGen) with €691,414 H2020 grant. SEKAB provides CelluAPP® pre-treatment and hydrolysis platform for converting cellulose to sugars; MetGen provides tailored enzymes for hydrolysis and bioconversion of Glucose to Fructose. Demonstrated >80% glucose yield from cellulose; production of >2,000 kg wood-based sugars during project.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Consortium partner in ReTAPP project. Avantium provides YXY technology for converting sugars into furanics and ultimately PEF resin (bio-based PET alternative). Develops novel glucose/fructose separation technology and parallel flow equipment for C5/C6 sugar feeds. Target market for biobased fructose estimated 1.5 million tons by 2021.

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest industrial enzyme company globally and a profiled player in the biofuel enzymes market alongside MetGen. Overlaps directly with MetGen's MetZyme® products in pulp & paper, biorefining, and starch processing, but with a far broader portfolio and global salesforce.

2IFF (DuPont Industrial Biosciences)
TypeBroad incumbent
Description

Major industrial enzyme and biocatalysis player following its absorption of DuPont's Industrial Biosciences unit. Competes with MetGen in tailored enzymes for biorefining and fibre processing, and is a profiled competitor in the biofuel enzymes market.

TypeDirect peer
Description

US-listed protein engineering company with a CodeEvolver® platform for developing tailored industrial enzymes — directly comparable to MetGen's ENZINE® platform. Competes for similar bio-based chemical, pharmaceutical, and food customer applications.

TypeDirect peer
Description

Specialist industrial enzyme company focused on starch, baking, and pulp & paper applications. Most directly overlaps with MetGen's MetZyme® LIGNO, PLATA, and BRILA pulp & paper enzyme solutions.

TypeEmerging player
Description

Swiss start-up developing sustainable, lignin-based materials (functional polymers, aromatic building blocks). Comparable to MetGen's METNIN™ platform as another emerging lignin valorization specialist targeting bio-based resins and aromatic chemicals.

TypeEmerging player
Description

Biomass conversion company using supercritical hydrolysis to produce cellulosic sugars and lignin fractions. Comparable to MetGen's SUNO™ / METNIN™ / PURECO™ biorefinery solutions stack, with overlapping customers in the 2G biorefinery and bio-based chemicals space.

TypeEmerging player
Description

French industrial biotech using engineered enzymes for plastics (PET) recycling and biorefinery. Comparable to MetGen in its protein-engineering-led approach and the move into bio-based plastics and circular chemistry applications.

TypeEmerging player
Description

Dutch renewable chemicals company developing the YXY plant-based PEF technology — a current customer of MetGen. Adjacent business model: also uses lignocellulosic sugars to produce bio-based polymers, making it a strategic customer/competitor in the wood-to-fructose-to-PEF value chain.

TypeEmerging player
Description

Carbon-capture-to-fuels biotech using gas fermentation to produce ethanol and chemicals. Tangentially comparable to MetGen as a high-profile industrial biotech scale-up pursuing biorefinery economics, though with a different feed gas/lignin stream.

TypeOthers
Description

Forest-industry major building biorefinery platforms for bio-based glycols, lignin, and fillers — comparable to MetGen's downstream customers and to the NewEnergyBlue / Futurity biorefineries MetGen is enabling. Useful as a customer/partner signal for bio-based scale-up trajectories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MetGen

Industrial Enzymes & Bio-Based Specialty Chemicalsmetgen.com

What MetGen does

MetGen Oy is a Finnish industrial biotechnology company founded in 2008 and headquartered in Kaarina, Finland with a second site in Geleen, Netherlands. The company designs and produces tailored industrial enzymes and enzymatic lignin-refining processes, built on two proprietary platforms: the ENZINE® protein-evolution and fermentation platform (capable of moving from concept to industrial enzyme production in under 12 months) and the METNIN™ lignin-refining technology (an enzymatic process operating at pH 11 and elevated temperatures to depolymerize and fractionate any lignin source into tailored molecular weight cuts). These platforms power a portfolio of MetZyme® enzyme products (LIGNO™, PLATA™, BRILA™, SUNO™, PURECO™) for pulp & paper and biorefinery applications, plus a family of formulated METNIN™ end-products (SHIELD, RESIN, NANOpolyol, Bioesters, and MICRO/ULTRA/NANO Fractions) for packaging, foams, resins, adhesives, and bioplastics.

MetGen firmographics

Firmographics
Name
MetGen
Legal name
MetGen Oy
Website
https://metgen.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

MetGen industry classification

Industry
Product category
Industrial Enzymes & Bio-Based Specialty Chemicals
NAICS
Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing (325194), Other Basic Organic Chemical Manufacturing (32519)
SIC
Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAMALAB
Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids)
SECONDARYIMAMALAE
Lignin-based Materials & Carbon Products (binders, resins, carbon fiber/activated carbon)
SECONDARYEUAAAHAJ
Biofuel Co-products & Byproduct Processing (DDGS, Glycerin, CO2, Lignin)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biofuels Production (Ethanol, Biodiesel, Renewable Diesel, SAF)

Keywords

  • Industrial enzymes
  • Lignin refining
  • Biorefinery solutions
  • Pulp and paper enzymes
  • Bio-based materials

Where MetGen is headquartered

Location

Headquarters

HQ city
Kaarina
HQ country
Finland
HQ region
Europe

Markets served

MetGen business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Technology Licensing (METNIN™ and Enzyme Production Systems): License fees plus potential royalties on METNIN™ lignin refining technology and enzyme production systems (e.g., SUNO™), with territory-specific and biorefinery-count licensing. Includes EPCM for licensees to build their own production sites.
  2. Direct Enzyme Product Sales (MetZyme®): Direct supply of tailored MetZyme® industrial enzyme products (BRILA™, LIGNO™, PLATA™, etc.) to P&P mills, biorefineries and packaging customers; MetGen has shipped material to Asia, North and South America, with capacity up to 5,000L deliveries.
  3. Joint Development & Co-Creation Revenue: Phased joint development engagements (3-month screening + 6–12 month genetic engineering) for co-creation of new enzymes and bioprocesses with industrial partners; fees dependent on manufacturing site selection and ownership/user rights.
  4. Public-Funded Project Grants (Horizon 2020 / BBI JU): Participation in 11 EU Horizon 2020 / BBI JU projects across consortia (e.g., SWEETWOODS with 21 M€ EU funding out of 43 M€ total project budget), contributing to over 110 M€ in total value-chain funding that supports technology development.
  5. METNIN™ Lignin Product Sales & Samples: Sales of formulated ready-to-use METNIN™ end-products (SHIELD, RESIN, NANOpolyol, Bioesters) and tailored lignin fractions (MICRO, ULTRA, NANO) with sample webshop for industrial customers.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom licensing of METNIN™ technology and enzyme production systems — quote-based, includes license fees and potential royalties
OtherMulti-year contractJoint Development phased program — project-based fees over screening and engineering phases
Unit PricingPay-as-you-goCustom enzyme product pricing (MetZyme®) — quote-based per customer substrate and volume
Unit PricingPay-as-you-goMETNIN™ end-product sales with sample webshop

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

MetGen product offering

Product offering

Core offering

MetGen designs, develops, and manufactures tailored industrial enzymes and lignin-based biochemicals through two proprietary technology platforms: the ENZINE® protein-evolution and fermentation platform and the METNIN™ enzymatic lignin refining technology. The company sells MetZyme® enzyme products (LIGNO™, PLATA™, BRILA™, SUNO™, PURECO™) to pulp & paper mills and biorefinery operators, and formulated METNIN™ end-products (SHIELD, RESIN, NANOpolyol, Bioesters, and MICRO/ULTRA/NANO Fractions) to packaging, foam, resin, and bioplastics manufacturers. Commercialization routes include direct product sales, technology licensing, and joint development engagements with industrial customers.

Product overview

MetGen delivers an integrated industrial biotechnology offering built on two proprietary technology platforms — the ENZINE® enzyme creation platform and the METNIN™ lignin refining process — which together power a portfolio of tailored MetZyme® enzyme products (LIGNO™, PLATA™, BRILA™, SUNO™, PURECO™) and a family of formulated METNIN™ lignin-based end-products (SHIELD, RESIN, NANOpolyol, Bioesters, and MICRO/ULTRA/NANO Fractions). These platforms and products are commercialized to industrial customers via four service lines: Biorefinery Solutions, Fibre Solutions, Licensing, and Joint Development. The product family is architected so ENZINE® generates the enzymes, MetZyme® products apply them to pulp-and-paper and biorefinery processes, and METNIN™ refines the lignin side-stream into value-added biochemicals — together creating a complete bio-based value chain from biomass to ready-to-use end products.

Differentiator

Problem solved

Functional benefit

Brands

  • ENZINE®: Technology platform combining protein evolution technology and fermentation, enabling recombinant expression of tailored enzymes that meet customer needs. Allows development of novel enzymes from idea to industrial production in less than 12 months.
  • METNIN™
  • MetZyme®
  • METNIN™ SHIELD
  • METNIN™ RESIN
  • METNIN™ NANOpolyol
  • METNIN™ Bioesters
  • METNIN™ Fractions
  • MetZyme® SUNO™
  • MetZyme® PURECO™
  • MetZyme® LIGNO™
  • MetZyme® PLATA™
  • MetZyme® BRILA™

Companies that use MetGen

Customer profile

Named customers15 records

Segments6 records

Ideal customer profiles5 records

MetGen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

MetGen partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered minor, flagship and core.

  • ResearchAndMarkets.com (Biofuel Enzymes Market Report)minorOthers · 26 November 2025MetGen listed as one of key industry players profiled in ResearchAndMarkets.com's Biofuel Enzymes Market Forecast 2025-2030 report. Global biofuel enzymes market projected to grow from USD 1.580 billion (2025) to USD 2.268 billion (2030) at 7.50% CAGR. Other profiled players include DuPont, Iogen Corporation, Novozymes, Codexis Inc.
  • NewEnergyBlueflagshipStrategic or Co-development Partner · 11 November 2024Commercial integration announced November 11, 2024 combining NewEnergyBlue's biomass conversion technologies with MetGen's enzyme and lignin fractionization capabilities. NewEnergyBlue's first U.S. biomass refinery in Mason City, Iowa expected to begin operations in 2027, producing 21M gallons biofuel and 150,000 tons clean lignin. Plans call for four additional American refineries fully incorporating Inbicon and MetGen technologies over five years. MetGen planning commercial lignin-to-chemicals project next to Kaarina laboratories for early 2026.
  • EnXylaScope Consortium (5 SMEs, 4 research institutes, 2 large industrial partners, 2 universities)coreStrategic or Co-development Partner · 1 January 2024EU-funded project consortium developing enzymes for unleashing xylan potential for consumer products in cosmetics, nutraceuticals, and personal care sectors. Encompasses culture collections, enzyme discovery, production systems, xylan production and modification, consumer product development and evaluation, scaled-up enzyme production, and LCA/sustainability assessment.
  • BIONEER ConsortiumcoreStrategic or Co-development Partner · 1 January 2024EU-funded BIONEER project aims to scale-up lignocellulosic biomass-derived platform chemicals (BIONEER Building Blocks) to replace bisphenol A derivatives, alkyl acrylates, vinyl pyrrolidine, vinyl acetate, and siloxanes in personal care and coatings markets. Builds on EnXylaScope and PERFECOAT RIA projects.
  • REDYSIGN ConsortiumcoreStrategic or Co-development Partner · 1 January 2024EU-funded REDYSIGN project developing bio-based, intelligent, and recyclable packaging for fresh meat distribution. Leverages lignocellulosic fibres, lignin, and sugars with integrated sensors for spoilage detection and cold chain monitoring; aims to advance recycling efficiency via identification markers and oxidation treatments.
  • ROBUSTOO Consortium (Gecco, bisy, InnoSyn, BSC, CIB, UAB, IRNAS, FCBA, ITB)coreStrategic or Co-development Partner · 1 January 2024EU-funded ROBUSTOO project for large-scale production of oxidative enzymes (unspecific peroxygenases, laccases, HMFOs) for bio-based chemicals and materials. Applications include bio-based resins for wood panels/3D printing, regio-/stereo-selective oxygenations for fine chemicals, and FDCA production from HMF.
  • RepsolminorStrategic or Co-development Partner · 27 October 2022MetGen won PITCCH 3rd Corporate Challenge round where Repsol sought SMEs with lignin conversion technology. Repsol will work on Proof of Concept together with MetGen on lignin valorization (METNIN products for packaging, resin and foam). Identified via PITCCH open innovation network which promotes collaborations between Big Corporations and SMEs/startups.
  • Technip EnergiescoreStrategic or Co-development Partner · 28 September 2022Memorandum of Understanding announced September 28, 2022 to bring METNIN™ refineries to market and jointly sell and execute EPC projects. Global engineering company shares mission of maximizing biomass value and replacing petrochemicals. Collaboration leverages Technip Energies' engineering, procurement and construction capabilities alongside MetGen's METNIN™ lignin refining technology.
  • Ivy Farm TechnologiescoreStrategic or Co-development Partner · 21 September 2022Joint Development Agreement announced September 21, 2022 with Oxford-based cultivated meat company. Agreement is powered by MetGen's ENZINE® Technology platform and aims to address food system climate impact through innovative science and technology.
  • Futurity Bio-VenturesflagshipOEM/ Whitelabel/ Licensing Partner · 20 September 2022License agreement (announced September 20, 2022) for Futurity to build and operate lignin-centric biorefineries using METNIN® Technologies in New Zealand. Futurity operates plantation forestry-based biorefinery in Tairāwhiti-Gisborne, producing Nano-fibrillated cellulose, PHBV and advanced lignins. License covers production of full range of high value lignin-based products including resins and adhesives, foams, composites, bio-based chemicals and polymers.
  • Graanul Biotech (Graanul Invest)flagshipStrategic or Co-development Partner · 1 January 2020Industry consortium leader of SWEETWOODS EU Flagship project (43 M€ total budget, 21 M€ EU grant under Horizon 2020 BBI). Brings together MetGen Oy, Global Bioenergies, Tecnaro GmbH, Armacell via Ultima GmbH, Recticel N.V., 2B Srl, Vertech Group and Spinverse Oy. MetGen contributes four novel biorefinery solutions: Tailored hydrolysis (SUNO™), Enzymatic lignin depolymerization (METNIN™), Lignocellulosic glucose isomerization (PURECO™), Glucose conversion to glucosone.
  • WoodZymes Consortium (Navigator Company, Fibre Excellence, FINSA, SOPREMA France, CIB, IRNAS, IATA-CSIC, RAIZ, CTP, FCBA)coreStrategic or Co-development Partner · 1 January 2018Consortium for WOODZYMES project (H2020/BBI JU 2018-2021) developing wood transforming enzymes (extremozymes) for pulp & paper, fibreboard manufacture, and insulation materials sectors. Brings together world-leading companies and research institutes from Portugal, France, Finland and Spain.
  • SEKAB E-TechnologycoreStrategic or Co-development Partner · 1 January 2016Consortium partner in ReTAPP project (Coordinator: MetGen) with €691,414 H2020 grant. SEKAB provides CelluAPP® pre-treatment and hydrolysis platform for converting cellulose to sugars; MetGen provides tailored enzymes for hydrolysis and bioconversion of Glucose to Fructose. Demonstrated >80% glucose yield from cellulose; production of >2,000 kg wood-based sugars during project.
  • Avantium Chemicals BVcoreStrategic or Co-development Partner · 1 January 2016Consortium partner in ReTAPP project. Avantium provides YXY technology for converting sugars into furanics and ultimately PEF resin (bio-based PET alternative). Develops novel glucose/fructose separation technology and parallel flow equipment for C5/C6 sugar feeds. Target market for biobased fructose estimated 1.5 million tons by 2021.

Scale indicators11 records

Expansion highlights6 records

MetGen competitors and assessment

Company assessment

Broad incumbents

  • Novonesis (formerly Novozymes): Largest industrial enzyme company globally and a profiled player in the biofuel enzymes market alongside MetGen. Overlaps directly with MetGen's MetZyme® products in pulp & paper, biorefining, and starch processing, but with a far broader portfolio and global salesforce.
  • IFF (DuPont Industrial Biosciences): Major industrial enzyme and biocatalysis player following its absorption of DuPont's Industrial Biosciences unit. Competes with MetGen in tailored enzymes for biorefining and fibre processing, and is a profiled competitor in the biofuel enzymes market.

Direct peers

  • Codexis: US-listed protein engineering company with a CodeEvolver® platform for developing tailored industrial enzymes — directly comparable to MetGen's ENZINE® platform. Competes for similar bio-based chemical, pharmaceutical, and food customer applications.
  • AB Enzymes: Specialist industrial enzyme company focused on starch, baking, and pulp & paper applications. Most directly overlaps with MetGen's MetZyme® LIGNO, PLATA, and BRILA pulp & paper enzyme solutions.

Emerging players

  • Bloom Biorenewables: Swiss start-up developing sustainable, lignin-based materials (functional polymers, aromatic building blocks). Comparable to MetGen's METNIN™ platform as another emerging lignin valorization specialist targeting bio-based resins and aromatic chemicals.
  • Renmatix: Biomass conversion company using supercritical hydrolysis to produce cellulosic sugars and lignin fractions. Comparable to MetGen's SUNO™ / METNIN™ / PURECO™ biorefinery solutions stack, with overlapping customers in the 2G biorefinery and bio-based chemicals space.
  • Carbios: French industrial biotech using engineered enzymes for plastics (PET) recycling and biorefinery. Comparable to MetGen in its protein-engineering-led approach and the move into bio-based plastics and circular chemistry applications.
  • Avantium: Dutch renewable chemicals company developing the YXY plant-based PEF technology — a current customer of MetGen. Adjacent business model: also uses lignocellulosic sugars to produce bio-based polymers, making it a strategic customer/competitor in the wood-to-fructose-to-PEF value chain.
  • LanzaTech: Carbon-capture-to-fuels biotech using gas fermentation to produce ethanol and chemicals. Tangentially comparable to MetGen as a high-profile industrial biotech scale-up pursuing biorefinery economics, though with a different feed gas/lignin stream.

Others

  • UPM Biochemicals: Forest-industry major building biorefinery platforms for bio-based glycols, lignin, and fillers — comparable to MetGen's downstream customers and to the NewEnergyBlue / Futurity biorefineries MetGen is enabling. Useful as a customer/partner signal for bio-based scale-up trajectories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

MetGen social profiles

Digital presence

MetGen compliance and trust

Trust signal

Compliance1 record

MetGen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MetGen leadership team

Management profile

Number of profiles

Profiles10 records

MetGen funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MetGen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MetGen

What does MetGen do?

MetGen designs, develops, and manufactures tailored industrial enzymes and lignin-based biochemicals through two proprietary technology platforms: the ENZINE® protein-evolution and fermentation platform and the METNIN™ enzymatic lignin refining technology. The company sells MetZyme® enzyme products (LIGNO™, PLATA™, BRILA™, SUNO™, PURECO™) to pulp & paper mills and biorefinery operators, and formulated METNIN™ end-products (SHIELD, RESIN, NANOpolyol, Bioesters, and MICRO/ULTRA/NANO Fractions) to packaging, foam, resin, and bioplastics manufacturers. Commercialization routes include direct product sales, technology licensing, and joint development engagements with industrial customers.

Is MetGen a public or private company?

MetGen is a private company. It is classified as venture growth investor backed and is currently operating.

When was MetGen founded?

MetGen was founded in 2008. It employs 11 to 50 people.

Where is MetGen based?

MetGen is headquartered in Kaarina, Finland, in the Europe region.

How does MetGen make money?

Five revenue lines are on record. Technology Licensing (METNIN™ and Enzyme Production Systems) is the primary driver. The others are direct Enzyme Product Sales (MetZyme®), joint Development & Co-Creation Revenue, public-Funded Project Grants (Horizon 2020 / BBI JU) and METNIN™ Lignin Product Sales & Samples.

Who are MetGen's main competitors?

Broad incumbents on record are Novonesis (formerly Novozymes) and IFF (DuPont Industrial Biosciences). Direct peers are Codexis and AB Enzymes. Emerging players are Bloom Biorenewables, Renmatix, Carbios, Avantium and LanzaTech. UPM Biochemicals is listed as an others.

Does MetGen have an API?

No public API is recorded for MetGen.

What industry is MetGen in?

MetGen's product category is Industrial Enzymes & Bio-Based Specialty Chemicals. Its primary akta.pro industry code is IMAMALAB, Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids), with a secondary code of IMAMALAE, Lignin-based Materials & Carbon Products (binders, resins, carbon fiber/activated carbon). Its NAICS code is 325194 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ANSA.itPremio Innovation Radar ad azienda genoveseReact4Life, a Genoa-based company, won a European Commission Innovation Radar 2021 prize for its organ-on-a-chip technology, which supports personalized drug development and accelerates new therapies. The prize was awarded in the health technology category, with other winners including MetGen, C2CA Technology, and Kypo.PR NewswireGlobal Technical Enzymes Industry Analysis, 2020-2026 - Featuring Key Players BASF, DuPont, Novozymes, DSM, Advanced Enzymes Technologies, Megazyme, Denykem, and MetGenResearchAndMarkets has published a market analysis report projecting the global technical enzymes market to reach USD 1.5 billion by 2026, growing at a CAGR of 4% from 2019. The study highlights key drivers such as environmental concerns and biofuel demand, while identifying major industry players including BASF, DuPont, Novozymes, and DSM.PR NewswireMetGen Earns Acclaim from Frost & Sullivan for its Unique, Customized Enzyme Technologies, METNIN™ and ENZINE®Frost & Sullivan awarded Finland-based MetGen Oy the 2019 European Technology Innovation Award for its enzyme technologies METNIN™ and ENZINE®, recognizing the company's solutions for lignin valorization and rapid enzyme development. METNIN™ enables complete valorization of lignin under harsh alkaline conditions (pH~11) and allows customization of properties such as solubility and glass transition temperature, while ENZINE® is a technology platform that significantly reduces enzyme development cycles for biomass processing applications. MetGen has signed licensing and joint technology development agreements with industrial partners to develop lignin-based products including resins, composites, bio-based chemicals, and polymers across sectors such as pulp & paper and biorefineries.FinSMEsMetGen Raises €2.2M in FundingMetGen Oy, a Finnish cleantech company, raised €2.2M in funding led by Sofinnova Partners' Sofinnova Green Seed Fund, with participation from Finnish Industry Investment and Finnvera. The company will use the funds for commercial roll-out and development of new enzymatic products for pulp and paper and biofuels industries.